Katalin Karikó will receive the Semmelweis Budapest Award on December 15. The award was established in 2009.
Katalin Karikó, a Széchenyi Award-winning Hungarian biologist and research professor at the University of Pennsylvania living in the United States of America, will receive the Semmelweis Budapest Award this year. For more than thirty years, the award-winning scientist has been investigating the clinical applicability of mRNA in order to use it as a therapeutic molecule. Based on his patent, it was completed in 2020 and is the world's first clinically proven third-generation Pfizer-BioNTech vaccine against Covid-19.
Semmelweis University's highly prestigious international award, the Semmelweis Budapest Award, was founded by the university's senate in 2009. The award is given to scientists working in the field of natural sciences who achieve globally recognized results, whose work shows a new path and serves the development of humanity. The award will be presented on Thursday, December 15.
Source. magyarhirlap.hu
Opening image, photo: MH/Péter Papajcsik
